Filtros de búsqueda

Lista de obras de

1990-2010: two decades of interferon-based therapy

artículo científico publicado el 14 de junio de 2011

8-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.

artículo científico publicado en 2018

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

artículo científico publicado en 2018

A Case Report of Hepatocellular Carcinoma 5 Years After HBsAg Loss in Chronic Hepatitis Delta: How Long Surveillance is Required?

artículo científico publicado en 2017

A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model

artículo científico publicado en 2013

A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction

artículo científico publicado en 2017

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

artículo científico publicado en 2011

Adefovir for chronic hepatitis B treatment: identification of virological markers linked to therapy response.

artículo científico publicado en 2008

Adherence to Lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrence

artículo científico publicado en 2007

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

artículo científico publicado en 2021

Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.

artículo científico publicado en 2016

Amino acid substitutions within HLA-B*27-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8+ T cells.

artículo científico publicado en 2018

An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay

artículo científico publicado en 2015

An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1).

artículo científico publicado en 2016

Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy

artículo científico publicado en 2008

Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population

artículo científico publicado en 2018

Analysis of the evolution in the circulation of HAV and HEV in eastern Spain by testing urban sewage samples.

artículo científico publicado en 2009

Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues

artículo científico publicado en 2010

Applicability of real-time PCR combined with melting curve analysis for the study of hepatitis B virus genome mutations

artículo científico publicado en 2003

Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide

scientific article published on 20 July 2020

Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection?

scientific article published on 01 January 2010

Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data

scientific article published on 29 April 2020

Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing.

artículo científico publicado en 2016

Baseline HCV-RNA levels in genotype 1 chronic hepatitis C patients: The role of different cut-off points

artículo científico publicado en 2016

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.

artículo científico publicado en 2009

Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant

artículo científico publicado en 2018

Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic response

artículo científico publicado en 2014

Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice.

artículo científico publicado en 2017

Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfection

article

Chronic hepatitis B: a critical appraisal of current approaches to therapy

artículo científico publicado en 2006

Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).

artículo científico publicado en 2017

Clinical application of estimating hepatitis B virus quasispecies complexity by massive sequencing: correlation between natural evolution and on-treatment evolution

artículo científico publicado en 2014

Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation

artículo científico publicado en 2002

Clinical management of drug-drug interactions in HCV therapy: challenges and solutions

artículo científico publicado en 2012

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.

artículo científico publicado en 2015

Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain

artículo científico publicado en 2006

Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus

artículo científico publicado en 2015

Conservation and variability of hepatitis B core at different chronic hepatitis stages

artículo científico publicado en 2020

Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs ⬇️

artículo científico publicado el 1 de diciembre de 2012

Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

artículo científico publicado en 2016

Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

article

Cuantificación del antígeno de superficie del virus de la hepatitis B: implicaciones clínicas

artículo científico publicado en 2011

Current therapies for chronic hepatitis B.

artículo científico publicado en 2003

Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection

artículo científico

De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection.

artículo científico publicado en 2008

Decompensated Liver Disease due to Primary Hepatic Amyloidosis: Is Liver Transplantation Still Mandatory?

artículo científico publicado en 2019

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.

artículo científico publicado en 2016

Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy.

artículo científico publicado en 2018

Digoxygenin-Labelled DNA-Probe: A Rapid Non-Radioactive Method for Hepatitis B Virus DNA Detection in Serum

Drugs in development for hepatitis B.

artículo científico publicado en 2005

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B

artículo científico publicado en 2019

Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients.

artículo científico publicado en 2009

Editorial: rapid disease progression in hepatitis delta-can we turn the tide? Authors' reply

artículo científico publicado en 2020

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

artículo científico publicado en 2017

Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.

artículo científico publicado en 2014

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs

scientific article published on 14 June 2019

Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection

artículo científico publicado en 2016

Efficacy and safety of a two-drug direct-acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6

artículo científico publicado en 2019

Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.

artículo científico publicado en 2014

Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study.

artículo científico publicado en 2011

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

artículo científico publicado en 2005

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

artículo científico publicado en 2018

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response

artículo científico publicado en 2017

Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System

artículo científico publicado en 2017

Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.

artículo científico publicado en 2013

Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities

artículo científico publicado en 2015

Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study

scientific article published on 26 October 2011

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

artículo científico publicado en 2014

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

article

Entecavir, FTC, L-FMAU, LdT and others

artículo científico publicado en 2003

Erratum to “A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction” [J Hepatol 67 (2017) 669–679]

scholarly article published in Journal of Hepatology

Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain

artículo científico publicado en 2008

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.

artículo científico publicado en 2015

Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection

artículo científico publicado en 2016

Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: A report of 9 cases ⬇️

artículo científico publicado el 1 de mayo de 2003

Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy

artículo científico publicado en 2017

Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis

artículo científico publicado en 2018

Faldaprevir and deleobuvir for HCV genotype 1 infection.

artículo científico publicado en 2013

Financial impact of two different ways of evaluating early virological response to peginterferon-alpha-2b plus ribavirin therapy in treatment-naive patients with chronic hepatitis C virus genotype 1.

artículo científico publicado en 2005

Flares during long-term entecavir therapy in chronic hepatitis B.

artículo científico publicado en 2016

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

scientific article published on 17 June 2020

Genotyping of hepatitis B virus--genotypes a to g by multiplex polymerase chain reaction

artículo científico publicado en 2008

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

artículo científico publicado en 2017

Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trial

scientific article published on 02 November 2019

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

artículo científico publicado en 2018

Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent

artículo científico publicado en 2015

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.

artículo científico publicado en 2015

Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)

article

HBV core region variability: effect of antiviral treatments on main epitopic regions

artículo científico publicado en 2011

HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?

artículo científico

HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection.

artículo científico publicado en 2016

HDV evolution-will viral resistance be an issue in HDV infection?

artículo científico publicado en 2018

Hepatic elastography. Position paper of the Catalan Society of Gastroenterology

artículo científico publicado en 2011

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

scientific article published on 22 August 2018

Hepatitis B Virus Infection and the Kidney: Renal Abnormalities in HBV Patients, Antiviral Drugs Handling, and Specific Follow-Up

article by Gilbert Deray et al published 2015 in Advances in hepatology

Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.

artículo científico publicado en 2008

Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials

artículo científico publicado en 2015

Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: Findings from the Antiretroviral Pregnancy Registry ⬇️

artículo científico publicado el 2 de julio de 2012

Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes

artículo científico publicado en 2005

Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy

scholarly article by Andrea Caballero published in October 2018

Hepatitis C Therapy: Game Over!

artículo científico publicado en 2016

Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts

artículo científico publicado en 2009

Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alpha-2b plus ribavirin

artículo científico publicado en 2004

Hepatitis C virus genotype 3: a genotype that is not 'easy-to-treat'.

artículo científico

Hepatitis C virus infection

artículo científico publicado en 2017

Hepatitis E virus epidemiology in industrialized countries

artículo científico publicado en 2003

Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B

scientific article published on 22 January 2020

High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain.

artículo científico publicado en 2015

High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods

artículo científico publicado en 2015

ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection

artículo científico publicado en 2015

Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients

scientific article published on 01 October 2006

Impact of comorbidities on patients outcomes after interferon-free therapy-induced viral eradication in hepatitis

artículo científico publicado en 2017

Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

artículo científico publicado en 2015

Impact of the COVID 19 Pandemic on HCV Elimination in Spain

artículo científico publicado en 2020

Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

scientific article published on 06 September 2014

Infrequent detection of hepatitis E virus RNA in pregnant women with hepatitis E virus antibodies in Spain

artículo científico publicado en 2010

Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study

artículo científico publicado en 2014

Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?

artículo científico publicado en 2002

Is telbivudine superior to lamivudine for the treatment of patients with chronic hepatitis B?

artículo científico publicado en 2008

JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1

scientific article published on 14 March 2019

JNJ-56136379, an HBV Capsid Assembly Modulator, is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection

artículo científico publicado en 2020

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

artículo científico publicado en 2014

Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients

scientific article published on 19 July 2019

Late presentation of chronic viral hepatitis for medical care: a consensus definition

artículo científico publicado en 2017

Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice

artículo científico publicado en 2015

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

artículo científico publicado en 2016

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

artículo científico publicado en 2015

Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia

artículo científico publicado en 2019

Long-term outcome after interferon therapy in patients with chronic hepatitis C.

artículo científico publicado en 2007

Long-term safety and efficacy of nucleo(t)side analogue therapy in hepatitis B.

artículo científico publicado en 2018

Management of direct-acting antiviral agent failures

artículo científico

Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B.

artículo científico publicado en 2009

Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8 T Cells and Evolve at the Population Level

scientific article published on 12 February 2019

Mutations in the basic core promoter region of hepatitis B virus. Relationship with precore variants and HBV genotypes in a Spanish population of HBV carriers.

artículo científico publicado en 2004

Natural history and management of hepatitis C: does sex play a role?

artículo científico publicado en 2014

New hepatitis C virus genotype 1 subtype naturally harbouring resistance-associated mutations to NS5A inhibitors

artículo científico publicado en 2017

New real-time-PCR method to identify single point mutations in hepatitis C virus.

artículo científico publicado en 2016

New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents

artículo científico publicado en 2010

No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection

artículo científico publicado en 2018

Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals

scientific article published on 17 October 2019

Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study

artículo científico publicado en 2013

Optimal management of chronic hepatitis B patients receiving nucleos(t)ide analogues

scientific article published on 01 February 2020

Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study

scientific article published on 08 April 2019

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy.

artículo científico publicado en 2015

Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series.

artículo científico publicado en 2011

Patterns of Resistance-associated Substitutions in Patients With Chronic HCV Infection Following Treatment with Direct-acting Antivirals

artículo científico publicado en 2017

Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis

artículo científico publicado en 2007

Predicted Effects of Treatment for HCV Infection Vary Among European Countries ⬇️

artículo científico publicado el 2 de agosto de 2012

Preparing the patient for success: treat or wait?

artículo científico publicado en 2013

Prevalence of hepatitis E virus infection in children in the northeast of Spain

artículo científico publicado en 2008

Prevention and treatment of hepatitis B virus recurrence after liver transplantation

Profiles and clinical management of hepatitis C patients in Spain: disHCovery study

artículo científico publicado en 2015

Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients

artículo científico publicado en 2005

Quantitative characterization of hepatitis delta virus genome edition by next-generation sequencing

artículo científico publicado en 2017

Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.

artículo científico publicado en 2010

Quasispecies dynamics in main core epitopes of hepatitis B virus by ultra-deep-pyrosequencing

artículo científico publicado en 2012

Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach

artículo científico publicado en 2013

Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4).

artículo científico publicado en 2015

Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response

artículo científico publicado en 2010

Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

artículo científico publicado en 2017

Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report

artículo científico publicado en 2016

Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues

artículo científico publicado en 2007

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

artículo científico publicado en 2012

Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantification

artículo científico publicado en 2014

Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: meta-analyses of randomized, controlled trials and implications for the future

artículo científico publicado en 2011

Ribavirin concentration determines treatment success of first-generation DAA-based chronic HCV therapy

artículo científico publicado en 2015

Role of Biomarkers in Guiding Cure of Viral Hepatitis B

scientific article published on 05 December 2019

Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment.

artículo científico publicado en 2015

Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CRE

artículo científico publicado en 2017

Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials

artículo científico publicado en 2019

Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

artículo científico publicado en 2014

Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection.

artículo científico publicado en 2014

Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study

artículo científico publicado en 2016

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2014

Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B

scientific article published on 15 June 2020

Simultaneous quantification and genotyping of hepatitis B virus for genotypes A to G by real-time PCR and two-step melting curve analysis

artículo científico publicado en 2006

Sporadic cases of acute autochthonous hepatitis E in Spain

artículo científico publicado en 2004

Study of hepatitis B virus quasispecies by ultra-deep pyrosequencing: Resolving the nitty-gritty

artículo científico publicado en 2014

Successful Continuation of HCV Treatment After Liver Transplantation

artículo científico publicado en 2016

Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab

artículo científico publicado en 2009

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

artículo científico publicado en 2020

Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.

artículo científico publicado en 2013

Telbivudine improves renal function in patients with chronic hepatitis B.

artículo científico publicado en 2013

Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

artículo científico publicado en 2019

Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection

artículo científico publicado en 2017

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

artículo científico publicado en 2016

Tenofovir discontinuation after long-term viral suppression in HBeAg negative chronic hepatitis B. Can HBsAg levels be useful?

artículo científico publicado en 2015

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.

artículo científico publicado en 2010

Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).

artículo científico publicado en 2014

Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B ⬇️

artículo científico publicado el 1 de agosto de 2012

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

artículo científico publicado en 2008

The Optimal Timing of Hepatitis C Therapy in Transplant Eligible Patients With Child B and C Cirrhosis: A Cost-Effectiveness Analysis

artículo científico publicado en 2016

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

artículo científico publicado en 2009

The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugs

scientific article published on 29 September 2018

The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment

artículo científico publicado en 2004

The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.

artículo científico publicado en 2017

Therapy with direct-acting antivirals for genotype 3 patients: interferon's last gasp?

artículo científico publicado en 2015

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

artículo científico publicado en 2010

Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin

artículo científico publicado en 2018

Too many people with viral hepatitis are diagnosed late - with dire consequences

scientific article published on 01 August 2019

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy

artículo científico publicado en 2018

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.

artículo científico publicado en 2017

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study

scientific article published on 25 June 2020

Triple therapy with boceprevir or telaprevir for treatment naïve HCV patients ⬇️

artículo científico publicado el 1 de agosto de 2012

Ultra-deep pyrosequencing analysis of the hepatitis B virus preCore region and main catalytic motif of the viral polymerase in the same viral genome

artículo científico publicado en 2011

Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome

artículo científico publicado en 2012

Use of the novel INNO-LiPA line probe assay for detection of hepatitis B virus variants that confer resistance to entecavir therapy

artículo científico publicado en 2008

Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA.

artículo científico publicado en 2004

Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis

artículo científico publicado en 2020

Viral Load Measurements in Individuals with Hepatitis C Virus Infection: on the European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C 2018

scientific article published on 23 December 2019

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

artículo científico publicado en 2002

Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B.

artículo científico publicado en 2014

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis.

artículo científico publicado en 2012

[Cytokines and liver cirrhosis]

artículo científico publicado en 2004

[Is the type of pegylated interferon important for response to treatment in patients with chronic hepatitis C infection?]

artículo científico publicado en 2008

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

scientific article published on 21 July 2020

hbsag levels can be used to rule out cirrhosis in hbeag positive chronic hepatitis b: results from the sonic-b study

scientific article published on 21 April 2020

Las especialidades médicas en España: ¿una puerta a la modernización? ⬇️

artículo científico publicado el 10 de mayo de 2003

Nuevos agentes para el tratamiento de la hepatitis C ⬇️

artículo científico publicado el 25 de noviembre de 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda